Clinical Trials and Related Research
Lung Foundation Australia established the Multi-centre Clinical Trials Network (MCTN) in 1998. This service works with leading research companies and provides access to fully qualified Investigator site(s) and assists with finding suitable patients predominately in the area of Lung Disease.
Why participate in a Clinical trial?
Investigators who participate in a clinical trial often benefit in many ways. Benefits may include: acquiring knowledge and familiarity about new treatments, being able to provide your patients with access to new treatments not yet available to the public and establishing a new revenue stream for your practice.
What the MCTN Community will provide?
By registering as an Investigator, the MCTN Community will assist in matching suitable clinical trials relating to your expertise, provide administrative assistance prior to the commencement and for the duration of the trial and help recruit eligible participants.
The MCTN Community does not conduct clinical trials but is a service provided to ensure trials are completed in compliance to regulations and legislation. The services provided may include promotion and advertisement of trials, the recruitment of participants and assistance in the coordination of Investigator meetings or Site Initiation Visits.
Patients usually are unaware of opportunities to participate in a clinical trial. By registering, you may be able to provide your patients with this opportunity.
Investigators are just as important as participants for the successful completion of clinical trials. Your participation is invaluable to advancing medical knowledge.
The Lung Foundation is committed in assisting you conduct your clinical trial successfully and efficiently.
Lung Foundation Australia’s Multi-Centre Clinical Trials Network (MCTN) is an established administration service, available to both Clinical Trial Sponsors and Contract Research Organisations (CROs). The service can provide access to both a large-scale Investigator network and a patient database. The MCTN is underpinned by an established subject recruitment campaign management system and was formed to support local, national and International studies.
The service does not compete with Institutions that undertake clinical trials, but aims to enhance the recruitment base so that, collectively, recruitment targets and tight study timelines can be met. On an International basis, Australia and New Zealand are viewed as “countries of choice” for conducting clinical research, both in terms of the logistics involved, as well as the excellent standard of clinical conduct that exists in this country, which in turn boosts confidence with the scientific conclusions reached.
The capacity of The Australian Lung Foundation MCTN to perform these services is based on the Lung Foundation’s extensive past experience working with a wide variety of entities.
More information can be found in the MCTN Capability Statement or contact Glenda Colburn on 07 3251 3600 or by email at email@example.com.
|National Health and Medical Research Council||www.nhmrc.gov.au|
|Therapeutic Goods Administration||www.tga.gov.au|
|Australian Cancer Trials||www.australiancancertrials.gov.au|
|Australian New Zealand Clinical Trials Registry||www.anzctr.org.au|
Liability of Multi-centre Clinical Trials Network (MCTN)
Subject always to the limitations imposed by law, Lung Foundation Australia’s MCTN disclaimers any and all warranties, either express or implied, statutory or otherwise.
The use of this content is at the users’ own risk. When using this page, the transmission of data may be out of the control of Lung Foundation Australia’s MCTN. As a consequence Lung Foundation Australia’s MCTN assumes no liability for or relating to the delay, failure, interruption or corruption of any data or other information transmitted in connection with use of Lung Foundation Australia’s MCTN content.
Without limitation Lung Foundation Australia, its servants, agents or providers make no representations or warranties in respect of the currency, accuracy, reliability or completeness of any communications or information provided on or through the use of Lung Foundation Australia’s MCTN content, software, text, graphics or links forming part of or associated with Lung Foundation Australia’s site.
Neither Lung Foundation Australia, its servants, agents, providers nor any associated third parties referred to or mentioned on Lung Foundation Australia’s MCTN page will be liable for any damages (including without limitation) incidental and consequential damages, personal injury, wrongful death, lost profits, lost earnings, damages resulting from lost data or business interruption resulting from the use of or inability to use the Lung Foundation Australia’s MCTN page or the content of the page whether based on warranty, contract, tort or any other legal concept and whether or not Lung Foundation Australia is advised of the possibility of such damages.